Latanoprost Qualigen (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the eye, which remodels the extracellular matrix of the ciliary muscle and increases uveoscleral outflow of aqueous humor, resulting in reduced intra‑ocular pressure.

The prescribing clinician determines the dose. Typically, one drop is instilled into the affected eye(s) once daily, usually in the evening, but the exact regimen should follow the healthcare professional’s instructions.

Safety of Latanoprost in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Latanoprost, a prostaglandin analog, primarily increases aqueous outflow, whereas timolol, a beta‑blocker, reduces aqueous production. Both lower intra‑ocular pressure, but prostaglandin analogs often achieve greater pressure reduction with once‑daily dosing and a different side‑effect profile.

Store the ophthalmic solution at room temperature, below 25 °C, in the original packaging. Protect it from light and moisture to maintain stability and potency.

Latanoprost is applied as a single drop into the conjunctival sac of the affected eye(s) using the supplied dropper. The patient should wash hands before use, avoid touching the tip to the eye or any surface, and follow the prescriber’s schedule.

Serious risks include severe ocular inflammation such as uveitis or keratitis, allergic reactions that may cause swelling or rash, and rare cases of sudden vision loss. Any of these symptoms require immediate medical attention.

Latanoprost should not be used by patients with known hypersensitivity to the drug or any component of the formulation, and it is contraindicated in eyes with active intra‑ocular inflammation such as uveitis.